News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
358,630 Results
Type
Article (14343)
Company Profile (127)
Press Release (344160)
Section
Business (112572)
Career Advice (451)
Deals (18597)
Drug Delivery (26)
Drug Development (31132)
Employer Resources (49)
FDA (8785)
Job Trends (7662)
News (172653)
Policy (12349)
Tag
Academia (1314)
Alliances (34586)
Alzheimer's disease (449)
Approvals (8769)
Artificial intelligence (131)
Bankruptcy (129)
Best Places to Work (6467)
Biotechnology (96)
Breast cancer (51)
Cancer (535)
Career advice (402)
Cell therapy (151)
Clinical research (23855)
Collaboration (293)
Compensation (52)
COVID-19 (1112)
C-suite (63)
Data (542)
Diagnostics (4734)
Earnings (37853)
Events (50209)
Executive appointments (168)
FDA (9068)
Funding (236)
Gene editing (50)
Gene therapy (101)
GLP-1 (188)
Government (1225)
Healthcare (9815)
Infectious disease (1159)
Inflammatory bowel disease (51)
Interviews (49)
IPO (7919)
Job creations (1434)
Job search strategy (360)
Layoffs (108)
Legal (2509)
Lung cancer (70)
Manufacturing (104)
Medical device (11317)
Medtech (11322)
Mergers & acquisitions (10769)
Metabolic disorders (119)
Neuroscience (548)
NextGen Class of 2024 (3529)
Non-profit (1512)
Northern California (688)
Obesity (58)
Opinion (67)
Patents (65)
People (32204)
Phase I (8792)
Phase II (10796)
Phase III (6975)
Pipeline (219)
Postmarket research (501)
Preclinical (3993)
Press Release (66)
Radiopharmaceuticals (149)
Rare diseases (90)
Real estate (3347)
Regulatory (9078)
Research institute (1266)
Resumes & cover letters (67)
Southern California (693)
Startups (2500)
United States (6937)
Vaccines (240)
Date
Today (22)
Last 7 days (361)
Last 30 days (1848)
Last 365 days (19126)
2024 (17463)
2023 (22096)
2022 (30813)
2021 (32513)
2020 (30539)
2019 (25797)
2018 (19459)
2017 (18871)
2016 (17761)
2015 (20560)
2014 (15177)
2013 (12743)
2012 (13781)
2011 (14066)
2010 (12826)
Location
Africa (314)
Arizona (96)
Asia (23643)
Australia (4118)
California (1651)
Canada (683)
China (126)
Colorado (98)
Connecticut (81)
Europe (48225)
Florida (256)
Georgia (80)
Illinois (176)
Indiana (95)
Japan (49)
Kansas (76)
Maryland (307)
Massachusetts (1155)
Michigan (138)
Minnesota (174)
New Hampshire (58)
New Jersey (519)
New York (473)
North Carolina (390)
Northern California (688)
Ohio (73)
Pennsylvania (350)
South America (504)
Southern California (693)
Texas (248)
Utah (57)
Washington State (229)
358,630 Results for "biostem technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
BioStem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies from ProgenaCare Global
November 21, 2024
·
7 min read
BioStem Technologies Reports Breakthrough Results with AmnioWrap2® in Retrospective Wound Care Study
BioStem Technologies Inc. today announced that an article validating its proprietary processing method and its placental allograft products has been published in the international, peer-reviewed journal, Health Science Reports.
June 26, 2024
·
5 min read
Business
BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior ExchangeStrategic Audit Completion Set to Enhance BioStem Technologies’ Market Position and Shareholder Value
BioStem Technologies Inc. today announced the successful completion of comprehensive audits for fiscal years 2022 and 2023.
April 24, 2024
·
5 min read
Policy
BioStem Technologies Granted Prioritized Examination for Wound Healing Patent
BioStem Technologies Inc. announced that the United States Patent and Trademark Office has granted the Company’s request for Prioritized Examination for its application for U.S. Patent 18/290,914.
May 6, 2024
·
4 min read
BioMidwest
BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts
BioStem Technologies Inc. announced that it has retained the services of Mr. Nick McCoy, who will lead BioStem’s Diabetic Foot Ulcer and Venous Leg Ulcer clinical trials process as a consultant to the Company.
April 30, 2024
·
5 min read
Business
BioStem Technologies Reports Record First Quarter Revenue of $41.9 Million
BioStem Technologies Inc., a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics, reported financial results for the first quarter ended March 31, 2024.
May 14, 2024
·
12 min read
Press Releases
BioStem Technologies to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
October 29, 2024
·
4 min read
Press Releases
BioStem Technologies, Inc. Files Form 10 with the Securities and Exchange Commission and Submits Nasdaq Application for Uplisting
October 1, 2024
·
6 min read
Press Releases
BioStem Technologies Initiates Nationwide Launch of Vendaje AC® with Venture Medical Following Established Reimbursement in All Medicare Administrative Contractor (MAC) Regions
October 29, 2024
·
6 min read
Press Releases
BioStem Technologies Establishes National Pricing for Vendaje AC® from the Center for Medicare Services and Provides Reimbursement in All MAC Regions
October 15, 2024
·
6 min read
1 of 35,863
Next
